Clinicogenomic and Histopathologic Analyses of Supermassive Intrahepatic Cholangiocarcinoma and the Role of Ablative Radiotherapy.

Saved in:
Bibliographic Details
Title: Clinicogenomic and Histopathologic Analyses of Supermassive Intrahepatic Cholangiocarcinoma and the Role of Ablative Radiotherapy.
Authors: Abi Jaoude J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiation Oncology, Stanford University, Stanford, California., Lau A; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yuan Y; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Meimoun NS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., De B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Liao K; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kouzy R; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Nieves-Jimenez HR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Poenisch F; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Balter PA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Brock KK; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sawakuchi GO; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Vauthey JN; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Tzeng CD; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Shamsutdinova D; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lazar AJ; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Chatterjee D; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee., Holliday EB; Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Smith GL; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Minsky BD; Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Das P; Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Koong AC; Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lee SS; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Tran Cao HS; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Javle M; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kwong L; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Koay EJ; Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ludmir EB; Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 May 15; Vol. 32 (10), pp. 2079-2087.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-25-3368